(Q35000396)

English

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

The cellular ratio of immune tolerance (immunoCRIT) is a definite marker for aggressiveness of solid tumors and may explain tumor dissemination patterns (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

34

object named as

Jalid Sehouli

0 references

Dominique Könsgen

12

object named as

Dominique Könsgen

0 references

Ivana Türbachova

1

object named as

Ivana Türbachova

0 references

Christoph Loddenkemper

23

object named as

Christoph Loddenkemper

0 references

30

object named as

Ignace Vergote

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Frederik Marmé

32

object named as

Frederik Marme

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

object named as

Udo Baron

29

1 reference

ORCID Public Data File 2021

25

object named as

Nina Babel

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Alexander Mustea

4

object named as

Alexander Mustea

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

24

object named as

Sven Mahner

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Tim Schwachula

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ines Vasconcelos

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Tina Baldinger

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Katherine A Jones

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Hermann Bujard

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Alexander Olek

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Klaus Olek

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Katharina Gellhaus

10

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ioana Braicu

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Christy Fryer

13

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Elisabetta Ravot

14

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Alexander Hellwag

15

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Nicole Westerfeld

16

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Oliver J Gruss

17

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Markus Meissner

18

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Mazahir T Hasan

19

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Michael Weber

20

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Ulrich Hoffmüller

21

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sven Zimmermann

22

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Els Berns

26

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Richard Adams

27

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Robert Zeilinger

28

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Tim Maughan

31

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Thorsten Dickhaus

33

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sven Olek

35

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

26 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1226-1235

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

The three Es of cancer immunoediting

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Tregs and rethinking cancer immunotherapy

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Regulatory T cells and treatment of cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

An essential role for Scurfin in CD4+CD25+ T regulatory cells

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Regulatory T cell lineage specification by the forkhead transcription factor foxp3

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Control of regulatory T cell development by the transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Natural regulatory T cells: mechanisms of suppression

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Regulation of CD8(+) T Cell Responses to Retinal Antigen by Local FoxP3(+) Regulatory T Cells

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Metastatic cancer cell

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Mechanisms of bone metastasis

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Prognostic role of platinum sensitivity in patients with brain metastases from ovarian cancer: results of a German multicenter study

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Borderline epithelial tumors of the ovary

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Epigenetic control of the foxp3 locus in regulatory T cells

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Quantitative DNA methylation analysis of FOXP3 as a new method for counting regulatory T cells in peripheral blood and solid tissue

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Epigenetic quantification of tumor-infiltrating T-lymphocytes

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

A TEST OF SIGNIFICANCE FOR THE RELATION BETWEEN m RANKINGS AND k RANKED CATEGORIES

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Tumor- and stromal cell-specific expression of topoisomerase IIα and HER-2/neu in primary and recurrent ovarian cancer: Results of a prospective study.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

International Collaborative Ovarian Neoplasm trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -a study of the OVCAD consortium

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

1 reference

https://api.crossref.org/works/10.4161%2FEPI.26334

21 January 2018

Identifiers

10.4161/EPI.26334

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

release_3p6oagx2fzhhlj63iof2ny3bua

1 reference

https://api.fatcat.wiki/v0/release/3p6oagx2fzhhlj63iof2ny3bua

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35000396&oldid=1856544030"